Another possible cell source for cardiac regenerative medicine: Reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells

Medical Hypotheses

Volumn 76, Issue 3, 2011, Pages 365-367

  Xie, Xinxing ^a   Sun, Aijun ^a   Huang, Zheyong ^a   Zhu, Wenqing ^a   Wang, Shijun ^a   Zou, Yunzeng ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ADULT STEM CELL; ARTICLE; CARDIAC REGENERATIVE MEDICINE; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; CELL TYPE; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; FIBROBLAST; HEALTH CARE SYSTEM; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; NONHUMAN; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

ADULT; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FIBROBLASTS; HEART; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS;

IPS;

EID: 79751525259     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.10.041     Document Type: Article

References (29)

1. Martin-Rendon E., Brunskill S.J., Hyde C.J., et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a system review. Eur Heart J 2008, 29:1807-1818.
2. Marelli D., Desrosiers C., El-Alfy M., et al. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant 1992, 1:383-390.
3. Karpov R.S., Popov S.V., Markov V.A., et al. Autologous mononuclear bone marrow cells during reparative regeneration after acute myocardial infarction. Bull Exp Biol Med 2005, 140:640-643.
4. Katritsis D.G., Sotiropoulou P.A., Karvouni E., et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 2005, 65:321-329.
5. Caspi O., Huber I., Kehat I., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infracted rat hearts. J Am Coll Cardiol 2007, 50:1884-1893.
6. Menasché P. Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol 2008, 45:545-553.
7. Nussbaum J., Minami E., Laflamme M.A., et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 2007, 21:1345-1357.
8. Wernig M., Meissner A., Foreman R., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
9. Huang R.C., Yao K., Zou Y.Z., et al. Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction. Zhonghua Yi Xue Za Zhi 2006, 86:1107-1110.
10. Ge J., Li Y., Qian J., et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 2006, 92:1764-1767.
11. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006, 367:113-121.
12. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:287-294.
13. Zhang X., Wei M., Zhu W., et al. Combined transplantation of endothelial progenitor cells and mesenchymal stem cells into a rat model of isoproterenol-induced myocardial injury. Arch Cardiovasc Dis 2008, 101:333-342.
14. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
15. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
16. Zhou Q., Brown J., Kanarek A., et al. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 2008, 455:627-632.
17. Motoyama H., Ogawa S., Kubo A., et al. In vitro reprogramming of adult hepatocytes into insulin-producing cells with viral vectors. Biochem Biophys Res Commun 2009, 385:123-128.
18. Vierbuchen T., Ostermeier A., Pang Z.P., et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
19. Takeuchi J.K., Bruneau B.G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 2010, 459:708-711.
20. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
21. Bartunek J., Croissant J.D., Wijns W., et al. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infracted myocardium. Am J Physiol Heart Circ Physiol 2007, 292:H1095-H1104.
22. Hahn J.Y., Cho H.J., Kang H.J., et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 2008, 51:933-943.
23. Wisel S., Khan M., Kuppusamy M.L., et al. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl] piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infracted heart through Bcl-2 expression. J Pharmacol Exp Ther 2009, 329:543-550.
24. Li W., Ma N., Ong L.L., et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007, 25:2118-2127.
25. Gnecchi M., He H., Noiseux N., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006, 20:661-669.
26. Yang Y.J., Qian H.Y., Huang J., et al. Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J 2008, 29:1578-1590.
27. Takeuchi J.K., Bruneau B.G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 2009, 459:654-655.
28. De Val S., Black B.L. Transcriptional control of endothelial cell development. Dev Cell 2009, 16:180-195.
29. Narmoneva D.A., Vukmirovic R., Davis M.E., et al. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 2004, 110:962-968.